Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term quality of life. Found 19 abstracts

Ralph N, Ng SK, Zajdlewicz L, Lepore SJ, Heathcote P, Kneebone A, Dunn JC, Chambers SK. Ten-year quality of life outcomes in men with prostate cancer. Psychooncology. 2019 Nov 03;.
Gore JL, du Plessis M, Santiago-Jimenez M, Yousefi K, Thompson DJ, Karsh L, Lane BR, Franks M, Chen DY, Bandyk M, Bianco FJ, Brown G, Clark W, Kibel AS, Kim HL, Lowrance W, Manoharan M, Maroni P, Perrapato S, Sieber P, Trabulsi EJ, Waterhouse R, Davicioni E, Lotan Y, Lin DW. Decipher Test Impacts Decision Making Among Patients Considering Adjuvant and Salvage Treatment After Radical Prostatectomy: Interim Results From the Multicenter Prospective PRO-IMPACT Study. Cancer. 2017 Aug;123(15):2850-9.   PMCID: PMC5573983
Gore JL, Plessis MD, Santiago-Jimenez M, Yousefi K, Thompson DJ, Karsh L, Lane BR, Franks M, Chen DY, Bandyk M, Bianco FJ, Brown G, Clark W, Kibel AS, Kim HL, Lowrance W, Manoharan M, Maroni P, Perrapato S, Sieber P, Trabulsi EJ, Waterhouse R, Davicioni E, Lotan Y, Lin DW. Decipher test impacts decision making among patients considering adjuvant and salvage treatment after radical prostatectomy: Interim results from the Multicenter Prospective PRO-IMPACT study. Cancer. 2017 Apr 19;.
Packel L, Fang CY, Handorf E, Rodoletz M. A 12-Week Exercise and Stress Management Pilot Program From Theory Through Implementation and Assessment. Rehabilitation Oncology. 2017 Oct;35(4):172-80.
Avkshtol V, Dong Y, Hayes SB, Hallman MA, Price RA, Sobczak ML, Horwitz EM, Zaorsky NG. A comparison of robotic arm versus gantry linear accelerator stereotactic body radiation therapy for prostate cancer. Res Rep Urol. 2016 Aug;8:145-58.   PMCID: PMC4993397
Kim SP, Gross CP, Nguyen PY, Smaldone MC, Thompson RH, Shah ND, Kutikov A, Han LC, Karnes RJ, Ziegenfuss JY, Tilburt JC. Specialty bias in treatment recommendations and quality of life among radiation oncologists and urologists for localized prostate cancer. Prostate Cancer and Prostatic Diseases. 2014 Jun;17(2):163-9.   PMCID: No NIH funding
Holland JC, Andersen B, Breitbart WS, Compas B, Dudley MM, Fleishman S, Fulcher CD, Greenberg DB, Greiner CB, Handzo GF, Hoofring L, Jacobsen PB, Knight SJ, Learson K, Levy MH, Loscalzo MJ, Manne S, McAllister-Black R, Riba MB, Roper K, Valentine AD, Wagner LI, Zevon MA, Nccn Distress Management Panel Mem. Distress Management Clinical Practice Guidelines in Oncology (TM). Journal of the National Comprehensive Cancer Network. 2010 Apr;8(4):448-85.   PMCID: not NIH funded
Sprangers MA, Sloan JA, Veenhoven R, Cleeland CS, Halyard MY, Abertnethy AR, Baas F, Barsevick AM, Bartels M, Boomsma DI, Chauhan C, Dueck AC, Frost MH, Hall P, Klepstad P, Martin NG, Miaskowski C, Mosing M, Movsas B, Van Noorden CJ, Patrick DL, Pedersen NL, Ropka ME, Shi QL, Shinozaki G, Singh JA, Yang P, Zwinderman AH. The Establishment of the GENEQOL Consortium to Investigate the Genetic Disposition of Patient-Reported Quality-of-Life Outcomes. Twin Research and Human Genetics. 2009 Jun;12(3):301-11.   PMCID: PMC 2824176
Barsevick AM, Whitmer K, Nail LM, Beck SL, Dudley WN. Symptom cluster research: Conceptual, design, measurement, and analysis issues. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT. 2006 Jan;31(1):85-95.
Movsas B, Scott C, Watkins-Bruner D. Pretreatment factors significantly influence quality of life in cancer patients: A radiation therapy oncology group (RTOG) analysis. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2006 Jul;65(3):830-5.
Padilla G, Ropka ME. Quality of life and chemotherapy-induced neutropenia. Cancer nursing. 2005 Jan;28(3):167-71.
Barsevick AM, Dudley W, Beek S, Sweeney C, Whitmer K, Nail L. A randomized clinical trial of energy conservation for patients with cancer-related fatigue. Cancer. 2004 Mar;100(6):1302-10.
Bruner DW, Hanlon A, Mazzoni S, Raysor S, Konski A, Hanks G, Pollack A. Predictors of preferences and utilities in men treated with 3D-CRT for prostate cancer. International Journal of Radiation Oncology Biology Physics. 2004 Jan;58(1):34-42.
Bruner DW, Movsas B, Konski A, Roach M, Bondy M, Scarintino C, Scott C, Curran W. Outcomes research in cancer clinical trial cooperative groups: The RTOG model. Quality of Life Research. 2004 Aug;13(6):1025-41.
Dreicer R, Manola J, Roth BJ, See WA, Kuross S, Edelman MJ, Hudes GR, Wilding G. Phase III trial of methotrexate, vinblastine, doxorubicin, and cisplatin versus carboplatin and paclitaxel in patients with advanced carcinoma of the urothelium - A trial of the eastern cooperative oncology group. Cancer. 2004 Apr;100(8):1639-45.
Hannoun-Levi JM, Mazeron JJ, Marsiglia H, Gerard JP. Partial breast irradiation: revolution or evolution?. Cancer Treatment Reviews. 2004 Nov;30(7):599-607.
Choucair AK, Scott C, Urtasun R, Nelson D, Mousas B, Curran W. Quality of life and neuropsychological evaluation for patients with malignant astrocytomas: RTOG 91-14. International Journal of Radiation Oncology Biology Physics. 1997 Apr;38(1):9-20.
Watkinsbruner D, Scott C, Lawton C, Delrowe J, Rotman M, Buswell L, Beard C, Cella D. Rtogs First Quality-of-Life Study - Rtog-90-20 - a Phase-Ii Trial of External-Beam Radiation with Etanidazole for Locally Advanced Prostate-Cancer. International Journal of Radiation Oncology Biology Physics. 1995 Nov;33(4):901-6.
Scott CB, Stetz J, Bruner DW, Wasserman TH. Radiation-Therapy Oncology Group Quality-of-Life Assessment - Design, Analysis, and Data Management Issues. Quality of Life Research. 1994 Jun;3(3):199-206.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term quality of life

quality of life prostate cancer KeyWords Plus: radiotherapy QUALITY-OF-LIFE quality-of-life fatigue survivors salvage therapy OUTCOMES prostatectomy RADICAL PROSTATECTOMY SURVIVAL scale survival cancer Oncology adjuvant therapy decisional conflict chemotherapy survivorship randomized controlled-trial symptom management symptom clusters pain depression lung-cancer Decipher 6-minute walk test adjuvant chemotherapy PACLITAXEL PLUS CARBOPLATIN BREAST-CANCER Nuclear Medicine & Medical Imaging Radiology impairment mental health phase-iii Anxiety cancer clinical-trials malignant astrocytomas adults Neoplasm Metastasis clinical trials Urology & Nephrology SENSITIVITY Male breast-cancer MEN eortc qlq-c30 psychology psychiatric-disorders Karnofsky performance active breathing control Clinical Neurology GENOME-WIDE ASSOCIATION brain-tumors validation prostatic neoplasms sleep quality index RECURRENCE brain-tumor patients PAIN distress trial design local control mindfulness elderly-women COMMUNITY ONCOLOGY palliative care technology self-rated health survey TWINS REARED APART cancer patients regression Cancer postoperative radiotherapy inventory marrow transplant Conflict (Psychology) DEFINITION Surveys and Questionnaires breast- outpatients pretreatment factors Middle Aged psychological symptoms partial breast irradiation NCCN Clinical Practice Guidelines Chemotherapy Multivariate Analysis questionnaires ADJUVANT CHEMOTHERAPY 20-year follow-up sexual function MANAGEMENT OBSTRUCTIVE PULMONARY-DISEASE randomized clinical-trial anxiety DECISION-ANALYSIS radiation-therapy CELL LUNG-CANCER HEALTH STATES ADJUSTED SURVIVAL ANALYSIS pathology COST-EFFECTIVENESS ANALYSIS preferences ENVIRONMENTAL-FACTORS elderly cancer-patients Salvage Therapy RESPONSE RATES psychiatric cost analysis patients SELF-RATED HEALTH Prostatectomy breast cancer stereotactic body radiation therapy Prostatic Neoplasms symptoms General & Internal Medicine PHYSICAL PERFORMANCE REGIMEN children treatment recommendations questionnaire Prospective Studies function mini-mental status exam genetic disposition MULTIPLE-SCLEROSIS conserving therapy INDIVIDUAL-DIFFERENCES functional assessment doxorubicin BREAST-CANCER SURVIVORS cognitive function RADIATION-THERAPY physical-activity urothelial carcinoma adjusted survival analysis METASTATIC BLADDER-CANCER STEM-CELL TRANSPLANTATION Quality of life and cisplatin (M-VAC) regimen supportive care TRENDS population antineoplastic agent outcomes Neutropenia
Last updated on Wednesday, February 05, 2020